FDA Approved: CARDURA XL — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved a supplemental application for CARDURA XL (doxazosin mesylate) by Viatris Specialty LLC, typically resulting in labeling changes for the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Hypertension

Drugs mentioned

• CARDURA XL (DOXAZOSIN MESYLATE)

Snippet

SUPPL AP for CARDURA XL (DOXAZOSIN MESYLATE)